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Introduction {#sec1}
============

The mouse immunoglobulin heavy-chain (*IgH*) locus contains a set of constant (C~H~) region exons, which span a genomic sequence of approximately 220 kb and determine the isotype and effector function of antibodies. B cells activated by antigen undergo *IgH* class switch recombination (CSR), a DNA deletion mechanism that replaces the default Cμ constant region for one of several downstream C~H~ exons (Cγ, Cε, or Cα) ([@bib38]). This process is strictly dependent on non-coding transcription initiated from intronic promoters located upstream of each set of C~H~ exons ([@bib7], [@bib54]). CSR long non-coding (lnc) RNAs are termed germline transcripts (GLTs) and include a non-coding first exon, which is spliced to downstream C~H~ exons. Distinct sets of cytokines induce GLTs from distinct C~H~ exons to promote CSR to that particular isotype, while GLTs upstream of the Cμ exon are produced constitutively ([@bib63]).

Transcription of each GLT first intron, which contain 1- to 10-kb-long sequences called switch (S) regions, promotes the formation of R-loops ([@bib11], [@bib55], [@bib69]). These RNA:DNA hybrid structures are formed between the G-rich and highly repetitive lncRNA and the template DNA ([@bib58], [@bib59], [@bib71]). R-loop formation results in non-template single-strand DNA (ssDNA) that may act as a substrate for activation-induced cytidine deaminase (AID), the enzyme that initiates CSR by deaminating cytidines to uracils ([@bib7]). Resulting U:G mismatches are subsequently processed into DNA double-strand breaks (DSBs) by mismatch and base-excision DNA repair proteins and two distinct S-regions are ligated by non-homologous end-joining proteins ([@bib38]).

In support of this R-loop mechanism, transgenic mouse models showed that a synthetic DNA fragment with a G-rich non-template strand can support CSR and inversion of Sγ1 reduces R-loop formation and CSR to IgG1 ([@bib61]). Both the negative supercoiling imposed by a transcribing polymerase ([@bib44]) and nascent RNA degradation by the RNA exosome complex ([@bib1]) have been proposed to expose S-region DNA to deamination by AID. AID targeting may rely on components of the transcription machinery at sites of transcriptional stalling through AID association with Spt5 ([@bib46]). Recent evidence also supports a post-transcriptional, RNA-guided mechanism for the targeting of AID to complementary S-region DNA. AID was demonstrated to bind G-quadruplex (G4) structures present in μGLT and αGLT introns and an AID mutant unable to bind G4 RNA abolishes CSR to IgG1 ([@bib72]). Notably, switch G4 RNAs were shown to occur following intron lariat debranching catalyzed by DBR1 ([@bib72]). These findings may explain earlier observations implicating a direct role for GLT in CSR ([@bib19], [@bib36], [@bib41], [@bib43]). It was shown that induction of spliced switch transcripts is sufficient to target CSR to IgG1, whereas transcription alone is not ([@bib36]). Possibly switch G4 RNA is closely regulated during CSR, even though it remains unclear how these highly structured RNAs can access DNA strands to target AID to *IgH* S-regions.

Recently, it has been shown that G4 or branched DNA structures act as preferred AID targets *in vitro* based on structural studies ([@bib52]). These reveal a bifurcated substrate binding-surface for AID that simultaneously binds two single-stranded sequences. Interestingly, AID appears to recognize both DNA and RNA with similar affinities, which may explain how AID binding to G4 RNA impacts on CSR ([@bib50], [@bib72]). The exact nature of structured AID substrates *in vivo* is unclear but may involve both RNA and DNA counterparts ([@bib50]). Consequently, AID targeting to S-regions may require DEAD-box RNA helicase activity to reorganize G4 RNA and R-loop structures.

DEAD-box proteins share a highly conserved helicase core consisting of two RecA-like domains connected by a short flexible linker that bind or remodel RNA and RNA-protein complexes. They are characterized by at least 13 conserved sequence motifs involved in ATP binding, ATP hydrolysis, and RNA binding, including the Walker A motif I and Walker B motif II Asp-Glu-Ala-Asp (DEAD) ([@bib35]). The DEAD-box RNA helicase 1 (DDX1) has been implicated in various aspects of RNA metabolism including pre-mRNA 3′end processing ([@bib2], [@bib8]), tRNA ligase catalyzed splicing ([@bib24], [@bib49]), mRNA transport ([@bib25]), RNA export ([@bib68]), and the maturation of DNA damage-induced micro-RNAs ([@bib18]). Also, DDX1 may be part of the cellular response to DSBs occurring at sites of active transcription where it was shown to be required for efficient repair ([@bib33], [@bib34]). A role for DDX1 in the innate immune response against viral infection has also been suggested as DDX1 together with DDX21 and DHX36 acts as a sensor of cytoplasmic double-strand RNA (dsRNA) ([@bib70]). Since DDX1 was previously identified in pull-down experiments using chromatin-bound AID as a bait ([@bib67]), we elected to investigate its potential role in CSR. We describe DDX1 as a critical effector of CSR that facilitates AID targeting to S-region DNA. We further elucidate the molecular mechanism whereby DDX1 acts on intronic switch G4 RNA to promote formation of S-region R-loops.

Results {#sec2}
=======

DDX1 Knockout Impairs CSR in B Cells {#sec2.1}
------------------------------------

In the spleen, B cells that encounter antigen are activated to proliferate as short-lived plasmablasts, undergo CSR and can enter into germinal centers (GCs). In the GC, B cells further differentiate into long-lived, antibody-secreting plasma cells. To examine whether changes in *DDX1* gene expression accompany the differentiation of mature B cell subsets, we compared *DDX1* mRNA levels in naive follicular B cells with activated plasmablasts, GC B cells and terminally differentiated plasma cells ([@bib5]). Interestingly, *DDX1* expression increased 2-fold upon B cell activation and remained elevated in plasma cells residing in the spleen or the bone marrow ([Figure S1](#mmc1){ref-type="supplementary-material"}A). This suggests that increased *DDX1* expression occurs at stages when B cells undergo CSR and differentiate into antibody-secreting plasma cells.

To directly test whether DDX1 controls CSR we activated splenic B cells *ex vivo*. Stimulation with bacterial lipopolysaccharide (LPS) and LPS plus interleukin-4 (IL-4) induces naive B cell proliferation, and switching from IgM to IgG3 and IgG1, respectively. We observed induction of γ3 and γ1 GLT and a gradual decrease in μ GLT levels over 4 days ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Levels of AID encoding *Aicda* mRNA, were also markedly increased. Finally, a consistent increase in DDX1 protein levels upon LPS or LPS plus IL-4 stimulation was detected at day 3 ([Figure S1](#mmc1){ref-type="supplementary-material"}C). For deletion of *DDX1* we treated B cells isolated from *DDX1*^loxP/loxP^ mice with recombinant TAT-Cre protein, which caused efficient excision of *DDX1* exon 5 from the genome ([Figures 1](#fig1){ref-type="fig"}A and 1B) and a near complete loss of DDX1 protein ([Figure 1](#fig1){ref-type="fig"}C). As CSR is linked to cell division ([@bib21]), we labeled cells with the fluorescent cell tracking dye carboxyfluorescein succinimidyl ester (CFSE) to access CSR independently of cell proliferation. Notably, a 2-fold reduction in surface IgG3 and IgG1 expression was observed in DDX1-deleted cells as compared to control B cells ([Figures 1](#fig1){ref-type="fig"}D and 1E). This did not result from impaired cell proliferation, as a similar decrease in IgG1 CSR levels was observed in cells that underwent different numbers of cell divisions ([Figure 1](#fig1){ref-type="fig"}F). We conclude that DDX1 is required for efficient CSR in primary B cells.Figure 1Impaired CSR in DDX1 Knockout B Cells(A) Diagram of conditional *DDX1* (*DDX1*^loxP^) and Cre-deleted *DDX1* (*DDX1*^del^) alleles. PCR primers are indicated.(B) PCR analysis of genomic DNA from *DDX1*^loxP/loxP^ splenic B cells treated with TAT-Cre (2 replicates).(C) Western blot of WT and DDX1-deleted (DDX1Δ) B cells (day 4, 2 replicates).(D) Flow cytometric analysis for surface IgG3 and IgG1 expression and CFSE in WT and DDX1Δ B cells stimulated for 4 days.(E) Quantification of CSR for cultures shown in (D). Each symbol represents B cell cultures from individual mice (n ≥ 3, mean ± SD).(F) Percentage of IgG1^+^ cells analyzed per number of cell divisions in CFSE-labeled LPS plus IL-4 cultures at day 4. One representative experiment with 3 mice per genotype (mean ± SD).(G) Serum Ig concentrations in naive WT and *DDX1* cKO mice. Each symbol represents individual mice and horizontal lines indicate the mean.(H) Antigen-specific IgG and IgM immune responses in WT and *DDX1* cKO mice immunized with ovalbumin (OVA) antigen. Serum was analyzed by ELISA and endpoint titers were determined (n = 2, mean ± SD; 3--7 mice in each time point except week 10 where 2--3 mice were analyzed). See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

To further evaluate whether DDX1 is required for CSR *in vivo*, we used B cell-specific conditional *DDX1* knockout mice. These were generated by expressing Cre recombinase specifically in activated B cells (*DDX1*^loxP/loxP^ *Aicda*-Cre^+/−^, *DDX1* cKO). Consistent with a role for DDX1 in CSR, sera from *DDX1* cKO mice showed normal levels of IgM and a general decrease in the steady-state levels of switched IgH isotypes compared to wild-type (WT) mice ([Figure 1](#fig1){ref-type="fig"}G). Upon *in vivo* immunization with ovalbumin (OVA) antigen in complete Freund's adjuvant, antigen-specific IgG responses were strongly increased in WT ([Figure 1](#fig1){ref-type="fig"}H). In contrast, serum levels of OVA-specific IgG were reduced in immunized *DDX1* cKO mice, whereas OVA-specific IgM were slightly increased compared to WT ([Figure 1](#fig1){ref-type="fig"}H). Total levels of switched IgH isotypes were also decreased in *DDX1* cKO mice after immunization, including IgG1 and IgG2c isotype that are strongly upregulated in WT mice ([Figure S1](#mmc1){ref-type="supplementary-material"}D). Also, we observed induction of GC B cells and plasmablasts after *DDX1* cKO mice immunization, albeit less than WT controls ([Figures S1](#mmc1){ref-type="supplementary-material"}E and S1F). Remarkably, most plasmablasts in immunized *DDX1* cKO mice have not undergone switching and retained expression of μ IgH ([Figure S1](#mmc1){ref-type="supplementary-material"}F). Yet, both WT and *DDX1* cKO splenocytes produce high levels of the switch-inducing cytokine interferon (IFN)-γ in response to OVA stimulation ([Figure S1](#mmc1){ref-type="supplementary-material"}G). Taken together, these results demonstrate that DDX1 deficiency severely impairs CSR *in vivo*.

Transcription Is Largely Unaffected in DDX1-Depleted B Cells {#sec2.2}
------------------------------------------------------------

To better characterize how DDX1 controls CSR, we employed the mouse CH12 cell line, which shows efficient IgM to IgA CSR following cytokine induction ([@bib42]). CH12 cells were stably depleted of DDX1 using lentivirus-expressing short hairpin RNA (shRNA) ([Figure 2](#fig2){ref-type="fig"}A). CH12 cells transduced with a control shRNA (non-targeting, shCtrl) efficiently switch from IgM to IgA (∼50% IgA^+^IgM^--^ cells), upon *in vitro* stimulation with anti-CD40, IL-4, and TGF-β (CIT) for 72 hr ([Figure 2](#fig2){ref-type="fig"}B). In contrast, DDX1 knockdown cell lines showed a 50% loss of IgA^+^IgM^--^ cells in CIT cultures ([Figures 2](#fig2){ref-type="fig"}B and 2C). In control cells stimulated with CIT, we observed lower proliferation when compared to unstimulated conditions, as reflected by higher CFSE levels or lower dilution ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Cell-cycle analysis revealed an increased proportion of CIT cells in the G1-phase of the cell cycle ([Figure S2](#mmc1){ref-type="supplementary-material"}B), likely due to AID-induced mutations and DNA repair mechanisms associated with CSR causing a G1 delay ([@bib60]). Surprisingly, knockdown of DDX1 resulted in increased proliferation rates and increased proportions of cells in the S-phase of the cell cycle upon CIT stimulation ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). However, based on the frequency of IgA^+^ cells as a function of CFSE dilution, we conclude that DDX1 is required for efficient CSR in CH12 cells independently of cell proliferation ([Figure S2](#mmc1){ref-type="supplementary-material"}C). We also performed CRISPR/Cas9-mediated gene inactivation of *DDX1* (exon 5) in CH12 cells but no homozygous deletions were obtained, suggesting that DDX1 is essential for viability ([@bib20]). A heterozygous clone with a frameshift mutation leading to a premature stop codon ([Figure S2](#mmc1){ref-type="supplementary-material"}D) was obtained and expanded in culture. However, *DDX1*^+/−^ CH12 cells show only a partial decrease in DDX1 protein levels and no effect on CSR as compared to WT cells ([Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F).Figure 2Transcription Profiling in DDX1-Depleted CH12 CellsCH12 cells transduced with shCtrl or shDDX1 were analyzed after 72 hr in unstimulated (UNS) or CIT-stimulated conditions.(A) Western blot for DDX1 and Tubulin loading control.(B) Flow cytometric analysis for surface IgM and IgA expression.(C) Quantification of CSR for CIT cultures shown in (B) (average of 2 clones for each shRNA; n \> 3, mean ± SD).(D) Quantitative PCR analysis of chRNA after 24 hr in UNS or CIT conditions. Unspliced μGLT and αGLT levels were normalized to unspliced *β-actin* transcript and shCtrl UNS (n = 2, mean ± SD).(E) Heatmap of 120 differentially expressed genes between shCtrl or shDDX1 CH12 cells in UNS or CIT conditions. Gene expression values (FPKM) are shown (fold change ≥2, false discovery rate \[FDR\] ≤0.05; n = 2). Hierarchical clustering identified 11 groups of genes (clusters I--XI) with similar patterns of expression change across the different samples analyzed. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

To determine whether impaired CSR in DDX1-depleted cells is associated with changes in gene transcription, we analyzed nascent transcript levels in chromatin-associated RNA (chRNA) from shCtrl and shDDX1 CH12 cells. The purity of chRNA following nuclear fractionation was confirmed by the presence of unspliced *β-actin* RNA in the chromatin but not nucleoplasm fractions ([Figure S2](#mmc1){ref-type="supplementary-material"}G). We next tested the effect of DDX1 depletion on nascent GLT levels in chRNA ([Figure 2](#fig2){ref-type="fig"}D). μGLT levels were relatively unaffected by CIT stimulation while αGLT increased significantly, consistent with constitutive μGLT and cytokine-induced αGLT transcription ([@bib63]). Of note, GLT levels were not substantially affected by DDX1 depletion ([Figure 2](#fig2){ref-type="fig"}D). Next, we performed high-throughput sequencing of chRNA (chRNA-seq) to measure genome-wide gene expression changes in DDX1-depleted CH12 cells. Most changes in differentially expressed genes were observed between unstimulated and CIT-stimulated conditions, irrespective of DDX1 knockdown ([Figure 2](#fig2){ref-type="fig"}E; [Table S1](#mmc2){ref-type="supplementary-material"}). The few genes that were differentially expressed between shCtrl and shDDX1 cells ([Figure 2](#fig2){ref-type="fig"}E, clusters VII and VIII) were equally affected under unstimulated and CIT-stimulated conditions. Overall, we demonstrate that DDX1 is required for efficient CSR but does not affect gene expression levels per se.

Decreased R-Loop Levels over *IgH* S-Regions in DDX1-Depleted B Cells {#sec2.3}
---------------------------------------------------------------------

Previous studies have reported the recruitment of DDX1 to sites of DNA damage containing RNA:DNA hybrids, where it may facilitate homologous recombination ([@bib33], [@bib34]). Because R-loop structures over S-regions have been implicated in CSR ([@bib61], [@bib69]), we evaluated R-loop levels over *IgH* genomic regions using the S9.6 RNA:DNA hybrid-specific antibody in DNA immunoprecipitation (DIP) assays ([Figure 3](#fig3){ref-type="fig"}A). We show that RNA:DNA hybrids were specifically enriched in regions flanking the Sμ repeats in unstimulated and CIT-stimulated shCtrl cells ([Figure 3](#fig3){ref-type="fig"}B) or upstream the Sα repeats in CIT-stimulated shCtrl cells ([Figure 3](#fig3){ref-type="fig"}C), consistent with previous studies ([@bib22], [@bib26]). Note that the S-region core repeats cannot be directly measured for R-loops by PCR due to its repetitive sequence nature. Interestingly, reduced R-loop levels were detected in Sμ and Sα regions in shDDX1 CH12 cells following CIT stimulation ([Figures 3](#fig3){ref-type="fig"}B and 3C). Similar results were obtained when DDX1 was transiently depleted from CH12 cells using short-interfering RNA (siRNA), confirming that reduced R-loop levels is a direct effect of DDX1 depletion ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C). Validation of our DIP approach and the specificity of the S9.6 antibody was shown by loss of RNA:DNA hybrid signals upon treatment with recombinant RNaseH ([Figures S3](#mmc1){ref-type="supplementary-material"}D and S3E). We conclude that DDX1 depletion results in reduced levels of R-loops over *IgH* S-regions once cells have been induced to undergo CSR.Figure 3Reduced R-Loop Levels over *IgH* S-Regions in DDX1-Depleted Cells(A) Diagram of the mouse *IgH* locus. Switch (S)-region core repeats (ovals) precede each set of constant region (C~H~) exons.(B and C) A conserved transcription unit comprising a non-coding intervening (I)-exon, an intronic S-region and a downstream set of C~H~ exons is expanded for μ (B) and α (C) regions. CH12 cells transduced with shCtrl or shDDX1 were analyzed by DIP with the S9.6 RNA:DNA hybrid-specific antibody (IP) or no antibody control (--), after 24 hr in UNS- or CIT-stimulated conditions. Probes employed (1--13) are indicated. Values were normalized both to probe 2 in each sample and probe 9 in shCtrl CIT cells in each experiment (n = 5, mean ± SD). Dashed line represents background signal (DIP levels for probe 2 in shCtrl UNS cells). See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

DDX1 Binds to G4 Structures in Intronic Switch RNAs {#sec2.4}
---------------------------------------------------

A notable feature of S-regions is that they are particularly enriched with clusters of guanines nucleotides (G-clusters) generally present among AID target motifs. Once transcribed as GLT, intronic G-clusters form G4 structures that have been shown to bind AID and somehow target it to S-region DNA ([@bib72]). We therefore tested the role of DDX1 in the G4 RNA-guided mechanism of CSR. We used biotinylated oligonucleotides containing four Sμ repeats in tandem (Sμ4G) in RNA pull-down assays ([Figure 4](#fig4){ref-type="fig"}A). Mutated Sμ4G lacking guanine clusters (Sμ4Gmut) cannot form G4 and was used as a negative control. We confirmed that Sμ4G forms G4 when stabilized by potassium (Sμ4G-K^+^) but not lithium (Sμ4G-Li^+^) cations, as shown by a higher molecular weight smear observed for Sμ4G-K^+^ samples following gel fractionation ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Also, circular dichroism spectroscopy showed a characteristic absorbance spectrum for parallel G4 structures in Sμ4G-K^+^, but not Sμ4G-Li^+^, samples (positive peak at ∼260 nm and negative peak at ∼240 nm, [Figure S4](#mmc1){ref-type="supplementary-material"}B). We next mixed pre-folded RNA oligonucleotides with whole-cell extracts from CH12 cells stably expressing tagged AID (AID^FLAG-HA^). As expected, AID was selectively pulled down with Sμ4G-K^+^ ([@bib72]). Notably, DDX1 was also pulled down using Sμ4G-K^+^ but not Sμ4G-Li^+^ or Sμ4Gmut oligonucleotides ([Figure 4](#fig4){ref-type="fig"}B). We then evaluated whether DDX1 binding was dependent on AID expression, as DDX1 has been shown to interact with chromatin-bound AID ([@bib67]). Extracts from AID-deficient CH12 cells obtained by CRISPR/Cas9-mediated gene inactivation (AID KO, [Figures S4](#mmc1){ref-type="supplementary-material"}C--S4E) were used in the same pull-down experiment. Notably, DDX1 was still pulled down with Sμ4G-K^+^ oligonucleotides ([Figure 4](#fig4){ref-type="fig"}C) suggesting AID-independent interaction of DDX1 with G4 RNA. A RNA dot-blot assay confirmed that RNA amounts recovered from streptavidin beads in different conditions were equivalent ([Figures 4](#fig4){ref-type="fig"}B and 4C, bottom). We conclude that DDX1 specifically binds to Sμ4G RNA containing G4 structures independently of AID.Figure 4DDX1 Binds to G4 Structures in Intronic Switch RNAs(A) RNA oligonucleotides consisting of 4 tandem Sμ repeats (Sμ4G) or a G-to-C mutant (Sμ4Gmut).(B and C) RNA pull-down assays with protein extracts from (B) AID^FLAG-HA^ or (C) AID KO CH12 cells, CIT stimulated for 48 hr. Western blots were analyzed for DDX1 and AID (FLAG tag) and RNA recovered from beads measured by dot blot. Representative results from at least 3 independent pull-downs.(D) Native electrophoretic mobility shift assays (EMSA) with ^32^P-labeled Sμ4G and Sμ4Gmut RNA oligonucleotides and rDDX1 (WT) or rDDX1-K52A (ATPase mutant) proteins (1, 2, or 4 μg). Representative results from at least 3 independent assays.(E--H) CH12 cells were transfected with a pcDNA3 vector expressing GFP or N-terminal GFP-tagged human DDX1-K52A cDNA (GFP::DDX1-K52A), and cultured in UNS or CIT-stimulated conditions.(E) Percentage of GFP^+^ cells 24 hr and 40 hr after transfection measured by flow cytometry (n = 4, mean ± SD).(F) Western blot of GFP^+^, fluorescence-activated cell sorted cells for DDX1 and Tubulin loading control (24 hr after transfection, 2 replicates).(G) Quantification of CSR in GFP^--^ and GFP^+^-gated cell populations (40 hr after transfection; n = 4, mean ± SD).(H) DIP analyses with S9.6 antibody (IP) or no antibody control (--), 24 hr after transfection in CIT-stimulated conditions using Sα region probe 9.Values were normalized to probe 2 in each sample and probe 9 in shCtrl CIT cells in each experiment (n = 3, mean ± SD). See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

We next performed native electrophoretic mobility shift assays (EMSAs) to show that recombinant human DDX1 (rDDX1) proteins ([@bib28]) directly bind ^32^P-labeled Sμ4G RNA oligonucleotides. RNA:protein complexes were readily detectable with increasing concentrations of rDDX1, as two major high-molecular-weight bands ([Figure 4](#fig4){ref-type="fig"}D). These two distinct complexes may reflect different conformations of the Sμ4G RNA or DDX1 dimer formation. Of note, binding of rDDX1 to Sμ4Gmut RNA was completely abolished ([Figure 4](#fig4){ref-type="fig"}D). A mutant version of rDDX1, where the conserved lysine residue in the Walker A motif I was mutated to alanine (rDDX1-K52A) ([@bib28]) was also tested. The Walker A motif is part of the ATP-binding site in DEAD-box helicases and is found in many NTPases ([@bib45]). Interestingly, rDDX1-K52A showed enhanced binding to Sμ4G RNA as compared to rDDX1 ([Figure 4](#fig4){ref-type="fig"}D). We confirmed rDDX1 and rDDX1-K52A bind specifically to G4 RNA and not G4 DNA ([Figure S4](#mmc1){ref-type="supplementary-material"}F) or ssDNA ([Figure S4](#mmc1){ref-type="supplementary-material"}G). Limiting amounts of rDDX1 proteins and oligonucleotides that form tetramolecular G4 substrates were used to compare protein binding affinity to G4 RNA and G4 DNA structures. As before, mutant rDDX1-K52A showed enhanced binding to G4 RNA compared to rDDX1 and a gel shift band of a higher molecular weight, which may reflect multiple rDDX1-K52A molecules binding to one or more G4 RNA. Notably, no G4 DNA interaction with either WT or mutant rDDX1 was detectible. Our observations reveal that DDX1 directly binds to G4 RNA and that an ATPase-deficient mutant forms a more stable complex, indicative of reduced substrate turnover.

The above findings prompted us to investigate whether DDX1-K52A functions as a dominant-negative mutant when introduced into CH12 cells. Following transient transfection of N-terminal GFP-tagged human DDX1-K52A cDNA into CH12 cells, we observed a strong selection against cells expressing DDX1-K52A ([Figure 4](#fig4){ref-type="fig"}E). Furthermore, GFP^+^ cells expressed only low levels of mutant DDX1 when compared to endogenous DDX1 protein levels ([Figure 4](#fig4){ref-type="fig"}F). Despite this, DDX1-K52A-expressing cells showed significantly reduced CSR toward IgA upon CIT stimulation ([Figure 4](#fig4){ref-type="fig"}G). The levels of IgA^+^ cells in CIT cultures was approximately half of that of cells expressing GFP only or untransfected cells (GFP^--^). Interestingly, we also detected reduced R-loop levels upstream of the Sα region in CIT-stimulated cells expressing DDX1-K52A when compared with cells expressing only GFP ([Figure 4](#fig4){ref-type="fig"}H). These results show that a DDX1 mutant deficient for ATP hydrolysis can compete effectively with an excess of WT DDX1 to reduce CSR. It is possible that DDX1-K52A sequesters G4 RNA away from WT DDX1. This will in turn impair the formation of RNA:DNA hybrids over *IgH* S-regions and so diminish efficient CSR.

DDX1 Modulates G4 and R-Loop Structures {#sec2.5}
---------------------------------------

We next aimed to connect our DDX1 and G4 RNA interaction data ([Figures 4](#fig4){ref-type="fig"}B--4D) with diminished R-loop levels over *IgH* S-region in DDX1-depleted cells ([Figure 3](#fig3){ref-type="fig"}). To do this, we employed pyridostatin (PDS), a generic G4-interacting small molecule. PDS has been show to bind and stabilize G4 structures at telomeres and other regions of the human genome where it induces DNA damage and cell-cycle arrest ([@bib56]). We therefore treated shCtrl and shDDX1 CH12 cells with PDS for a 4-hr period, which did not affect cell division ([Figure S5](#mmc1){ref-type="supplementary-material"}A). DIP analysis confirmed that similar levels of R-loops were detected after 4 or 24 hr of CIT stimulation ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Interestingly, we observed a 2-fold decrease in R-loop levels upstream Sμ and Sα regions in PDS-treated shCtrl cells when compared with DMSO controls ([Figures 5](#fig5){ref-type="fig"}A and 5B). To rule out the possibility that decreased R-loop levels in PDS-treated cells is due to stabilization of G4 structures on the non-template DNA stand of S-regions ([@bib12], [@bib15]), we employed the G4 RNA-specific derivative carboxyPDS (cPDS) ([@bib13]). As with PDS, we observed a 2-fold decrease in R-loop levels upstream Sμ and Sα regions in cPDS-treated shCtrl cells ([Figures 5](#fig5){ref-type="fig"}A and 5B). In contrast, when DDX1 was depleted similar R-loop levels were detected between DMSO and PDS or cPDS conditions. These results suggest that G4 RNA stabilization reduces R-loops over *IgH* S-regions in effect antagonizing DDX1.Figure 5DDX1 and G4 RNA-Dependent R-Loops in *IgH* S-Regions(A and B) CH12 cells transduced with shCtrl or shDDX1 were analyzed by DIP with S9.6 antibody (IP) or no antibody control (--). Cells were cultured in CIT-stimulated conditions with DMSO (Control), the G4 stabilizer pyridostatin (PDS, 10 μM), the G4 RNA-specific derivative carboxypyridostatin (cPDS, 10--40 μM) or the splicing inhibitor Pladienolide B (PlaB, 1 μM) for 4 hr. DIP signals shown for upstream Sμ region (probe 4) (A) and Sα region (probe 10) (B). Values were normalized to shCtrl DMSO (n ≥ 3, mean ± SD).(C--E) *In vitro* RNA:DNA hybrid assay using ^32^P-labeled tetramolecular G4 RNA and complementary DNA strands. Reactions were performed with 1 μg WT or an ATPase mutant (K52A) of rDDX1 at 25°C for 10 min (C and D) or 10, 20, and 30 min (E). (D) RNaseH treatment of RNA:DNA hybrids. Data shown in (C) and (D) are representative of at least 3 independent assays. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Next, we evaluated whether limiting the production of G4 RNA decreased R-loop levels over *IgH* S-regions. ShCtrl and shDDX1 CH12 cells were treated with the spliceosome inhibitor Pladienolide B (PlaB) as G4 RNA has been shown to derive from switch RNA introns ([@bib72]). When cells were treated with PlaB and CIT stimulation for 4 hr, we observed 50% lower levels of R-loops upstream Sμ and Sα regions in shCtrl cells as compared to DMSO controls ([Figures 5](#fig5){ref-type="fig"}A and 5B). Notably, this PlaB effect was not evident in DDX1-depleted cells. The possibility that splicing inhibition decreases R-loop levels per se and is not due to decreased accumulation of intronic G4 RNA was tested by treating cells with PlaB only after 20 hr of CIT stimulation ([Figure S5](#mmc1){ref-type="supplementary-material"}C). In this case, a similar abundance of Sμ-region R-loops was observed in both PlaB-treated and DMSO control cells. Sα-region R-loops were however slightly decreased under these conditions. As a control, transcription elongation was inhibited using Actinomycin D (ActD) or 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) after 20 hr of CIT stimulation. A marked decrease in S-region R-loop levels in shCtrl and shDDX1 CH12 cells was observed ([Figure S5](#mmc1){ref-type="supplementary-material"}D). We used qPCR to confirm increased levels of unspliced GLT in the presence of PlaB and a robust inhibition of μ and α GLTs with both ActD and DRB ([Figure S5](#mmc1){ref-type="supplementary-material"}E). We conclude that when the accumulation of intronic switch RNA is prevented from the onset of CIT stimulation, the levels of R-loops over *IgH* S-regions are decreased by half even in the presence of DDX1.

To directly test whether DDX1 can convert G4 RNA into RNA:DNA hybrids, *in vitro* assays were carried out using ^32^P-labeled tetramolecular G4 RNA and complementary DNA strands. Higher-order G4 RNA:protein complexes were detected in the presence of WT or K52A mutant rDDX1 protein, confirming DDX1 binding to G4 RNA structures ([Figure 5](#fig5){ref-type="fig"}C). Notably, a distinct band was also detected when both rDDX1 and complementary DNA strands were used ([Figure 5](#fig5){ref-type="fig"}C). To confirm that this band is a RNA:DNA hybrid, we verified its sensitivity to RNaseH treatment ([Figure 5](#fig5){ref-type="fig"}D). Importantly, the intensity of the RNA:DNA hybrid signal was diminished when the rDDX1-K52A mutant was used even when the reaction was allowed to proceed for longer periods of time ([Figure 5](#fig5){ref-type="fig"}E). These *in vitro* experiments demonstrate that rDDX1 acts on G4 RNA structures to convert them into RNA:DNA hybrids. Taken together, we predict that DDX1 acts to promote the conversion of switch G4 RNA into S-region R-loops at the *IgH* locus.

AID Binding to *IgH* S-Regions Is Dependent on DDX1 {#sec2.6}
---------------------------------------------------

The ability of DDX1 to bind G4 RNA prompted us to investigate whether impaired CSR in DDX1-depleted cells is due to reduced AID binding to S-region DNA. We observed a significant reduction of AID occupancy upstream Sμ and Sα regions in DDX1-depleted cells by chromatin immunoprecipitation (ChIP) ([Figures 6](#fig6){ref-type="fig"}A and 6B), even though we detected near equal amounts of AID in whole-cell and nuclear extracts in shCtrl and shDDX1 CH12 cells ([Figure 6](#fig6){ref-type="fig"}C). To clearly distinguish AID-specific signal from background levels, we determined ChIP signals in AID KO CH12 cells ([Figures 6](#fig6){ref-type="fig"}A and 6B). Strikingly, AID binding to *IgH* S-regions in DDX1-depleted cells was reduced to background levels. Because AID is a DNA mutator enzyme, it has low nuclear abundance compared to the cytoplasm, as observed by immunofluorescence (IF) staining ([Figure S6](#mmc1){ref-type="supplementary-material"}A). Although nuclear AID IF signals were slightly reduced in DDX1-depleted cells ([Figure S6](#mmc1){ref-type="supplementary-material"}B), this small difference could not account for the strong decrease on AID occupancy at *IgH* S-regions ([Figures 6](#fig6){ref-type="fig"}B and 6C). Similarly, co-immunoprecipitation experiments showed that only a small proportion of nuclear AID (less than 5%) directly interacts with DDX1 ([Figures 6](#fig6){ref-type="fig"}D and 6E), possibly the fraction that is chromatin bound ([@bib67]). Thus, it is unlikely that DDX1 recruits AID through direct protein-protein interactions. Instead, we predict that, in B cells undergoing CSR, DDX1 is required for efficient AID targeting to S-regions via switch G4 RNA. In effect, DDX1 may act to increase AID retention on the non-template DNA strand by promoting R-loop formation over S-regions.Figure 6Reduced AID Binding to *IgH* S-Regions in DDX1-Depleted CellsCH12 cells transduced with shCtrl or shDDX1 were cultured in CIT-stimulated conditions and analyzed after 24 hr.(A and B) AID ChIP analysis in μ (A) and α (B) regions. Values shown for antibody (IP) or IgG control are expressed as percentage of Input (n = 3, mean ± SD). AID KO CH12 cells were used to determine background levels (dashed line represents probe 2 signal).(C) Western blot of whole-cell and nuclear protein extracts for DDX1 and AID. Purity of nuclear extracts is shown by absence of cytoplasmic Tubulin, and CTCF levels were used as loading control. Amount of nuclear extract loaded is 15 times increased compared to the equivalent amount of whole cell extracts (WCEs). Data are representative of 3 independent experiments.(D and E) Co-immunoprecipitation assays with anti-DDX1 antibody and nuclear protein extracts from (D) AID^FLAG-HA^ or (E) WT CH12 cells CIT stimulated for 24 hr. Western blots were analyzed for DDX1, AID (or FLAG tag), and the tRNA ligase subunit RTCB as a positive control. Representative results from 2 independent pull-downs on each cell type.(F) Frequency of Sμ mutations (shCtrl normalized; n = 4, mean ± SD). Number of mutations per total number of bp analyzed and percentage of mutation in recombined Sμ DNA sequences in each experiment are shown in [Figure S7](#mmc1){ref-type="supplementary-material"}A.(G) Number of Sμ mutations at each nucleotide, expressed per 10^3^ bp (n = 4). Unique Sμ-Sα sequences were amplified from genomic DNA extracted from shCtrl (50 sequences) or shDDX1 (62 sequences) CH12 cells cultured in CIT conditions for 72 hr.See also [Figures S6](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"}.

Next, we determined the effect of DDX1 depletion on Sμ mutation frequency and nucleotide specificity in DNA sequences from Sμ-Sα recombination products in CH12 cells. Overall decreased levels of Sμ mutation were detected after DDX1 knockdown ([Figure 6](#fig6){ref-type="fig"}F and [Figure S7](#mmc1){ref-type="supplementary-material"}A), specifically at G/C base pairs ([Figure 6](#fig6){ref-type="fig"}G), which is consistent with diminished AID occupancy. To further extend this analysis, we mapped recombination breakpoints across both Sμ and Sα regions in 100-bp bins relative to PCR primer positions ([Figure S7](#mmc1){ref-type="supplementary-material"}B). We observed a clear overrepresentation of Sμ recombination sites within bin F, particularly in shDDX1 cells. Detailed analysis of these Sμ breakpoints in shCtrl cells revealed a strong preference for recombination with Sα sequences within bin L ([Figure S7](#mmc1){ref-type="supplementary-material"}B) and a characteristic 9- to 10-nt length of complementary nucleotides or microhomology (MH) at the Sμ-Sα breakpoint ([Table S2](#mmc1){ref-type="supplementary-material"}). In contrast, for shDDX1 cells around half of the Sμ breakpoints within the bin F were recombined to Sα sequences within bin R ([Figure S7](#mmc1){ref-type="supplementary-material"}B) and showed 1 nucleotide length of Sμ-Sα MH ([Table S3](#mmc1){ref-type="supplementary-material"}). The length of MH regions present at S-S junctions reflects the end-joining processes that ligate DSBs. CSR primarily depends on canonical non-homologous end joining (NHEJ) mechanisms for DSB repair but sometimes cells employ an alternative NHEJ repair pathway characterized by larger stretches of MH present at S-S junctions ([@bib3]). Therefore, we analyzed the length of MH regions at all Sμ-Sα recombination products. The majority of Sμ-Sα junctions in shCtrl CH12 cells share between 0 and 4 nt of MH between donor and acceptor sequences ([Figure S7](#mmc1){ref-type="supplementary-material"}C). However, a considerable proportion of Sμ-Sα junctions revealed more than 4 nt of MH, reflective of alternative NHEJ mechanisms. This pattern was also observed in DDX1 knockdown cells, although there was a significant increase in the percentage of Sμ-Sα junctions with a single-nucleotide homology ([Figure S7](#mmc1){ref-type="supplementary-material"}C). We conclude that the skewed distribution of Sμ-Sα recombination breakpoints in DDX1-depleted cells underlies the prevalence of Sμ-Sα junctions with a single-nucleotide homology. However, in the context of CSR both canonical and MH-mediated NHEJ mechanisms still operate upon DDX1 depletion.

Discussion {#sec3}
==========

We identify DDX1 as a DEAD-box RNA helicase required for CSR at the *IgH* locus. We provide evidence that DDX1 directly binds to G4 structures present within intronic switch RNA and by so doing targets AID to S-region DNA to promote CSR. We suggest that switch G4 RNA is modulated by DDX1-dependent mechanisms leading to R-loop formation over *IgH* S-regions ([Figure 7](#fig7){ref-type="fig"}). This post-transcriptional mechanism of R-loop formation contrasts with the view that that R-loops exclusively form co-transcriptionally when RNA exits RNA polymerase II during transcription and anneals with the template DNA strand ([@bib59]). The presence of G-clusters has been described as a key determinant of co-transcriptional R-loop formation as these clusters may act to nucleate thread-back of RNA into the DNA duplex behind the elongating polymerase ([@bib58], [@bib71]). We propose that post-transcriptional R-loop formation also relies on the presence of G-clusters in intronic switch RNA to form G4 structures that are recognized by DDX1 and target AID to *IgH* S-regions through RNA:DNA base-pairing. Previous studies have reported that limiting the generation of switch RNA introns by shRNA-mediated knockdown of the lariat debranching enzyme DBR1 had no detectable effect on R-loop levels ([@bib72]). Possibly sufficient G4 RNA remained in these DBR1-depleted cells to still allow full R-loop formation. We predict that both co-transcriptional and post-transcriptional mechanisms may cooperate to allow efficient CSR ([Figure 7](#fig7){ref-type="fig"}).Figure 7Model for DDX1 Role in CSR(A) RNA polymerase II (Pol II) makes switch transcripts, which are spliced to release the G4 containing intron. Intron lariat intermediates are debranched by the DBR1 enzyme as previously shown ([@bib72]). This converts the intron lariat into its linear form prior to folding into G4 RNA structures. Presumably, switch transcripts are trimmed by 5′ and 3′ exonucleases. G4 RNA and AID are then targeted to the S-region DNA through the action of the RNA helicase DDX1 that promotes the formation of R-loops. Hypothetically, hybrid G4 RNA:DNA structures could also occur in the non-template DNA strand ([@bib50]).(B) R-loops form behind elongating Pol II in S-region and recruit AID to the single-strand DNA.

Recent studies have demonstrated that G4 RNAs are globally unfolded in eukaryotic cells, presumably due to their deleterious effects on gene expression ([@bib17]). These findings have led to the suggestion that G4 RNAs are under tight regulation and are restricted to particular cell types or stages. We anticipated that B cells induced to undergo CSR provide a clear example of such regulation as a specific mechanism to target AID to the *IgH* locus ([@bib72]). Previously, only the DEAD/DEAH-box family RNA helicases DHX36, DHX9, and DDX21 have been shown to act on G4 RNA *in vitro* ([@bib6], [@bib10], [@bib39]). Our findings now demonstrate a physiological role for DDX1 in B cells undergoing CSR as part of the molecular machinery that modulates switch G4 RNA and R-loop structures. Importantly, we demonstrate that DDX1 cKO mice have reduced levels of switched Ig both at steady state and following immunization. While it is possible that DDX1 is involved in other aspects of B cell activation that can affect antibody responses, these data constitute definitive evidence for a role for G4 RNA in CSR physiology.

Recent studies show that AID deaminates ssDNA more robustly in the context of structured substrates, such as G4 or branched structures ([@bib52]). Interestingly, AID recognition occurs on single-stranded overhangs, either of DNA or RNA nature. In this context, G4 RNA-dependent targeting of AID to S-regions could rely on the DDX1-mediated formation of hybrid RNA:DNA structures, perhaps in the form of combined G4 and R-loops ([Figure 7](#fig7){ref-type="fig"}). However, whether such G4-R-loop structures are present at the *IgH* locus remains to be experimentally tested ([@bib50]). G4 DNA structures have been previously reported to be present on the non-template DNA strand of Sμ and Sγ regions *in vitro* ([@bib12], [@bib15]). However, other studies failed to detect such G4 DNA structures in Sγ3 and Sγ2b regions in LPS-stimulated B cells ([@bib69]). It would be important to evaluate the exact nature of G4 structures present *in vivo* at the *IgH* locus, as a G4 RNA-mediated AID targeting mechanism may also occur at non-Ig loci ([@bib72]). So far, only anti-sense ([@bib47]) and convergent transcription at super-enhancers ([@bib40], [@bib51], [@bib65]) have been shown to be involved in inappropriate targeting of AID at non-Ig hotspots by providing ssDNA substrates.

Many DEAD-box family members can only catalyze the unwinding of short dsRNA (≤14 bp) by local strand separation, a process reduced by increased substrate stability (GC content) ([@bib57]). Interestingly, DHX36 has been suggested to resolve G4 RNA structures by a similar mechanism employed by DEAD-box helicases on dsRNA ([@bib9]). Possibly the partial unwinding of switch G4 RNA by DDX1 is facilitated by simultaneous base-pairing of unfolded RNA to S-region DNA in a R-loop structure. In this context, exosome activity could expose the template DNA strand for RNA annealing ([@bib1]). Alternatively, anti-sense transcription at S-regions could also render the template DNA strand free to base pair with switch RNA ([@bib48]). Also, exposed stretches of ssDNA have been proposed to occur in S-regions as a result of R-loop collapse following RNaseH action or negative supercoiling behind transcribing RNA polymerase II ([@bib44], [@bib69]).

DDX1-mediated R-loop formation downstream of G4 RNA may also be coordinated through interaction of DDX1 with other protein factors. Previous studies have demonstrated that DDX1 has higher affinity for ADP then ATP, which might cause the protein to be predominantly found in a dead-end ADP-bound form at cellular nucleotide concentrations ([@bib28]). It has been suggested that DDX1 recycling relies on interactions with other proteins through its unique SPRY domain, known to function as a protein-protein interaction platform ([@bib27], [@bib28]). This may explain why our *in vitro* results show only partial DDX1-dependent conversion of G4 RNA into RNA:DNA hybrids. In a cellular context DDX1 is part of different multimeric protein complexes, such as tRNA ligase ([@bib49]), the Drosha microprocessor ([@bib18]), and the dsRNA sensor DDX1-DDX21-DHX36 complex ([@bib70]). The tRNA ligase has been previously implicated in the control of antibody secretion in plasma cells, where it mediates unconventional splicing of the mRNA encoding for the transcription factor XBP1 as part of the unfolded protein response ([@bib24]). It will be interesting to determine which interacting proteins are functionally linked to the role of DDX1 in CSR.

DDX1 has been associated with cellular events downstream of DNA damage and its phosphorylation by ATM precedes recruitment to sites of DSBs containing RNA:DNA structures ([@bib33]). In this context, DDX1 may be required to clear RNA from DSBs located within transcription units. This may preserve end-resected DNA in a single-strand conformation and so enable homology-directed DSB repair ([@bib34]). In DDX1-depleted cells, we detected a skewed distribution of recombination breakpoints in *IgH* S-regions, also reflected in the length of MH at S-S junctions. While these effects might be a direct consequence of defective AID targeting, the role of DDX1 in homology-directed DSB repair may also relate to *IgH* recombination. A recent study proposed that R-loops have important roles downstream of AID targeting, by contributing to replication origin specification that promotes DSB resolution in CSR ([@bib66]). Future experiments are required to establish whether DDX1 has a role on CSR steps downstream of AID targeting, such as in the resolution of DSBs.

In summary, we reveal the DEAD-box RNA helicase DDX1 as a molecular player in the post-transcriptional, RNA-guided mechanisms of AID targeting during CSR. Furthermore, we uncover a previously unanticipated role for DDX1-dependent G4 RNA remodeling in the regulation of R-loop levels over *IgH* S-regions. These findings may well extrapolate to other molecular functions of G4 RNA.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Purified anti-mouse/rat CD40 (HM40-3)eBioscience16-0402-81Purified anti-mouse CD16/CD32 (2.4G2)BD Biosciences553141PE anti-mouse CD19 (1D3)eBioscience12-0193-82PCP-Cy5.5 anti-mouse CD19 (1D3)eBioscience45-0193-82PE anti-mouse CD95 (Jo2)BD Biosciences561985Alexa Fluor 488 anti-human/mouse GL-7 (GL-7)eBioscience53-5902-82PE anti-mouse CD138 (281-2)Biolegend142503FITC anti-mouse IgM (eB121-15F9)eBioscience11-5890-82Biotin anti-mouse IgA (11-44-2)eBioscience13-5994-82Biotin anti-mouse IgG3 (R40-82)BD Biosciences553401Biotin anti-mouse IgG1 (A85-1)BD Biosciences553441Alexa Fluor 488 anti-mouse μ-heavy-chainThermoFischerA21042Alexa Fluor 488 anti-rabbit IgGThermoFischerA11034FITC anti-BrdU (clone 3D4)BioLegend364104Mouse monoclonal anti-RNA:DNA hybrids (S9.6)HybridomaMouse polyclonal anti-DDX1Novus BiologicalsH00001653-A01Rabbit polyclonal anti-DDX1ProteinTech11357-1-APMouse monoclonal anti-HSPC117/FAAP (RTCB)Santa Cruzsc-393966Rabbit monoclonal anti-AID (30F12)Cell Signaling4949Mouse monoclonal anti-AID (L7E7)Cell Signaling4975Rabbit polyclonal anti-AIDChaudhuri lab[@bib7]Rabbit polyclonal anti-FLAG tag (PA1-984B)ThermoFischerPA1-984BMouse monoclonal anti-FLAG tag (M2)-HRPSigma-AldrichA8592Rabbit polyclonal anti-ActinSigma-AldrichA2066Mouse monoclonal anti-Tubulin (B-5-1-2)Sigma-AldrichT5168Rabbit polyclonal anti-Histone H3Abcamab1791Rabbit polyclonal anti-CTCFMillipore07-729Anti-mouse IgG1 heavy-chain-HRPAbcamab97240Anti-mouse IgG (h+l)-HRP (ELISA detection)BethylA90-516PPurified anti-mouse IgM (II/41) (ELISA capture)BD Biosciences553435Anti-mouse IgM-HRP (ELISA detection)Sigma-AldrichA8786**Chemicals, Peptides, and Recombinant Proteins**EndoFit OvalbuminInvivoGenvac-povaAlbumin from chicken egg white (Grade V)Sigma-AldrichA5503Complete Freund's AdjuvantSigma-AldrichF5881Incomplete Freund's AdjuvantSigma-AldrichF5506Lipopolysaccharide (LPS) *E. coli* O55:B5Sigma-AldrichL2880Lectin from *Arachis hypogaea* (PNA), biotin conjugateSigma-AldrichL6135Recombinant murine IL-4Peprotech214-14Recombinant human TGF-β1R&D240-BPuromycin dihydrochlorideSigma-AldrichP8833Pyridostatin trifluoroacetate salt (PDS)Sigma-AldrichSML-0678Carboxypyridostatin trifluoroacetate salt (cPDS)Balasubramanian labPladienolide B (PlaB)Santa CruzSc-391691Actinomycin D (ActD)Sigma-AldrichA94155,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB)Sigma-AldrichD1916Polybrene (Hexadimethrine bromide)Sigma-AldrichH9268Carboxyfluorescein succinimidyl ester (CFSE)Biolegend4227015-bromo-2′-deoxyuridine (BrdU)Sigma-AldrichB5002TAT-CRE RecombinaseMilliporeSCR508Recombinant human DDX1 (amino acids 1--728)Meinhart Lab[@bib28]Recombinant human DDX1-K52A (amino acids 1--728)Meinhart Lab[@bib28]**Critical Commercial Assays**Amaxa Cell Line Nucleofector Kit RLonzaVCA-1001Mouse B cell isolation KitMiltenyi Biotec130-090-862ProcartaPlex mouse antibody isotyping kitThermoFischerEPX070-20816-901Ribo-Zero rRNA Removal kitIlluminaMRZH11124NEBNext Ultra Directional RNA Library Prep kitNew England BiolabsE7420SNEBnext multiplex Oligos (Index Primers Set 2)New England BiolabsE7500SProcartaPlex Mouse Antibody Isotyping Panel 2 7plexThermoFisherEPX070-20826-901IFN gamma Mouse ELISA KitThermoFisherBMS606**Deposited Data**chRNA-seq dataThis paperGEO: [GSE95635](ncbi-geo:GSE95635){#intref0010}Raw image filesMendeley Data<https://data.mendeley.com/datasets/z747pf6sd9/draft?a=c2b73047-5f9c-4ad9-b65a-9894f4fedfb0>**Experimental Models: Cell Lines**Mouse: CH12 cellsKhamlichi Lab[@bib42]Mouse: CH12-AID^FLAG-HA^ cellsReina-San-Martin Lab[@bib23]Mouse: CH12 shCtrl cellsThis paperN/AMouse: CH12 shDDX1 cellsThis paperN/AHuman: HEK293TATCCCRL-11268**Experimental Models: Organisms/Strains**C57BL/6N-Ddx1^tm1a(EUCOMM)Hmgu/Cnrm^ miceInfrafrontier/EMMAEM:08387ROSA26::FLPe miceThe Jackson LabJAX stock 003946*Aicda*-Cre miceBusslinger Lab[@bib31]**Oligonucleotides**Sμ4G RNA GAGCUGGGGUGAGCUGG\
GGUGAGCUGGGGUGAGCUGGGGUIDT[@bib72]Sμ4G mut RNA GAGCUGCGCUGAGCUGCGCU\
GAGCUGCGCUGAGCUGCGCUIDT[@bib72]Tetramolecular G4 RNA (A~15~G~5~A~15~) AAAAAAAAA\
AAAAAAGGGGGAAAAAAAAAAAAAAADharmacon[@bib10]Complementary DNA (T~15~C~5~T~15~) TTTTTTTT\
TTTTTTTCCCCCTTTTTTTTTTTTTTTSigma-AldrichN/ATetramolecular G4 DNA (A~15~G~5~A~15~) AAAAAAAAAA\
AAAAAGGGGGAAAAAAAAAAAAAAADharmaconN/ASingle-stranded DNA ATCGGAATGTATGA\
GAATAGAAGAGATAATGAATAATAGAASigma-Aldrich[@bib14]shDDX1 (mouse *DDX1* exon 19) GATGTGGT\
CTGAAGCTATTAASigma-AldrichN/ASMARTpool: siGENOME Ddx1 siRNADharmaconM-052098-00Anti-Luc siRNA1DharmaconD-002050-01*DDX1* gRNA (mouse *DDX1* exon 5) TCATACAC\
TATCTGGATAACGGGSigma-AldrichN/A*Aicda* gRNA1 (mouse *Aicda* 5′UTR) CCTAAGA\
CTTTGAGGGAGTCAAIDTN/A*Aicda* gRNA1 (mouse *Aicda* 5′UTR/exon1) GTCAC\
GCTGGAGACCGATATGGIDTN/ASee [Table S4](#mmc1){ref-type="supplementary-material"} for primer sequencesSigma-AldrichN/A**Recombinant DNA**Plasmid: pLKO.1-puroSigma-AldrichSHC001Plasmid: pLKO.1-shCtrlSigma-AldrichSHC002Plasmid: pLKO.1-shDDX1This paperN/APlasmid: psPAX2Addgene\#12260Plasmid: pMD2.GAddgene\#12259Plasmid: pSpCas9(BB)-2A-Puro (PX459)Addgene\#62988Plasmid: hCas9_D10AAddgene\#41816Plasmid: pcDNA3.1ThermoFischerV790-20**Software and Algorithms**BWA[@bib32]Cutadapt 1.8.3[@bib37]Bedtools[@bib53]UCSC bedGraphToBigWig tool[@bib29]Cufflinks 2.2.0[@bib64]

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to the Lead Contact, Nicholas J. Proudfoot (<nicholas.proudfoot@path.ox.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Cell lines {#sec4.3.1}

CH12 cells ([@bib42]) were grown in RPMI-1640 culture medium containing 10% heat-inactivated fetal bovine serum (FBS, GIBCO), 100 U/mL of penicillin, 0.1 mg/mL of streptomycin (GIBCO), 5% NCTC-109 medium (Sigma-Aldrich), and 10 mM β-mercaptoethanol at 37°C in a 5% CO~2~ atmosphere. For CH12-AID^FLAG-HA^ ([@bib23]) and shRNA-expressing CH12 cell lines the medium was further supplemented with puromycin (2 μg/mL; Sigma-Aldrich).

### Mice {#sec4.3.2}

Mice with the conditional C57BL/6N-Ddx1^tm1a(EUCOMM)Hmgu/Cnrm^ allele (obtained from Infrafrontier, European Mouse Mutant Archive (EMMA)) were crossed with FLPeR mice (obtained from the Jackson Laboratory) to generate the *DDX1*^loxP^ allele. Both *DDX1*^loxP/loxP^ and *Aicda*-Cre ([@bib31]) mice were maintained on the C57BL/6J genetic background and genotyping was performed by PCR (see [Table S4](#mmc1){ref-type="supplementary-material"} for primer sequences). The WT *DDX1* allele was identified as a 777-bp and the *DDX1*^loxP^ allele as a 919-bp PCR fragment. Mice were kept at specified pathogen free conditions and littermates of the same sex were randomly assigned to experimental groups. All animal experiments were performed in accordance with Home Office (UK) regulations and approved by the University of Oxford Local Ethical Committee.

### Primary B cell cultures {#sec4.3.3}

Naive B cells were isolated from spleens of 8-10 week old mice by magnetic depletion using the B cell isolation kit (Miltenyi Biotech). For *DDX1* deletion, purified B cells (\> 95% CD19^+^ cells) were washed 3x with Opti-MEM (ThermoFischer) and cultured at 10 × 10^6^ cells/ml in Opti-MEM with 200 U TAT-Cre recombinase for 45 min at 37°C. Subsequently, TAT-Cre was inactivated by adding FBS at a final concentration of 10%, cells were washed once with RPMI-1640 culture medium and then cultured at 37°C in a 5% CO~2~ atmosphere. Cells were harvested 1 day after TAT-Cre addition for analysis of deleted *DDX1* alleles on genomic DNA, identified as a 380-bp PCR fragment (see [Table S4](#mmc1){ref-type="supplementary-material"} for primer sequences). DDX1 protein depletion was analyzed 4 days after TAT-Cre treatment on total protein extracts by western blot.

Method Details {#sec4.4}
--------------

### Immunization {#sec4.4.1}

Mice (6-9 week old) were immunized subcutaneously in the flank with 100 μg endotoxin-depleted ovalbumin (EndoFit, Invivogen) formulated in Complete Freund's adjuvant (Sigma-Aldrich) as prime, and 4 weeks later as booster in Incomplete Freund's adjuvant (Sigma-Aldrich). Blood was taken every two weeks and sera separated and frozen at −80°C. Mice were euthanized at week 2 or week 10 post-immunization and spleens were harvested for further analyses.

### ELISA and Multiplex Immunoassay {#sec4.4.2}

Serum Ig concentrations in naive (8-12 week old) and immunized mice were measured using a Procarta Multiplex Immunoassay (ThermoFischer) according to manufacturer's instructions. Ovalbumin-specific IgG and IgM responses in immunized mice were measured by ELISA in SpectraPlate-96 HB plates (PerkinElmer). Ovalbumin-specific IgG levels were determined using 10 μg/mL ovalbumin (grade V, Sigma-Aldrich) in 0.1M NaHCO~3~ buffer pH 8.5 to coat plates at 4°C overnight. After blocking with 1% BSA in PBS, serum serial dilutions were incubated at room temperature for 2 hr. HRP-labeled anti-mouse IgG (Bethyl) antibody was used for detection. For ovalbumin-specific IgM detection, serum serial dilutions were incubated on plates coated with 1 μg/mL anti-mouse IgM capture antibody (BD Biosciences) in PBS. Subsequently, 10 μg/mL biotinylated ovalbumin was added and incubated at 4°C overnight followed by HRP-labeled anti-mouse IgM antibody detection. HRP activity was developed following addition of 1-Step Ultra TMB-ELISA Substrate Solution (ThermoFischer) according to manufacturer's instructions. Endpoint titers were calculated as a measurement of relative concentration using a cutoff of 2x the mean of a negative control reading (naive serum).

### *In vitro* antigen recall responses in splenocytes {#sec4.4.3}

Splenocytes were plated at 0.5 × 10^6^ cells/200 μL in RPMI-1640 culture medium in the presence of 50 μg/mL ovalbumin (EndoFit, Invivogen). After 3 days, IFNγ concentration in the culture supernatant was calculated using ELISA (ThermoFischer) according to manufacturer's instructions.

### CSR induction and chemical treatments {#sec4.4.4}

Primary B cells were activated at a density of 0.8 × 10^6^ cells/mL in the presence of 25 μg/ml lipopolysaccharide from *Escherichia coli* O55:B5 (LPS, Sigma-Aldrich) or LPS plus 10 ng/mL recombinant murine IL-4 (Peprotech) for 3-4 days, to induce proliferation and CSR to IgG3 and IgG1, respectively. To induce CSR to IgA, CH12 cells were cultured at a density of 0.02 × 10^6^ cells/mL in the presence of 1 μg/mL purified anti-mouse/rat CD40 (HM40-3, eBioscience), 10 ng/mL recombinant murine IL-4 (Peprotech) and 2 ng/mL recombinant human TGF-β1 (R&D Systems) (CIT) for 3 days. Cells were cultured at a density of 0.1 × 10^6^ cells per mL for analysis at 24 hr or 4 hr after CIT stimulation and treated at a final concentration of 10 μM pyridostatin (PDS, Sigma-Aldrich), 10-40 μM carboxypyridostatin (cPDS, ([@bib13])), 1 μM pladienolide B (PlaB, Santa Cruz) ([@bib30]), 5 μg/mL actinomycin D (ActD, Sigma-Aldrich) or 150 μM 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB, Sigma-Aldrich) for 4 hr using DMSO as vehicle.

### Flow Cytometry analyses {#sec4.4.5}

CSR was evaluated by cell surface staining with purified anti-mouse CD16/CD32 (BD Biosciences), FITC-conjugated anti-mouse IgM (eBiosciences), biotin-conjugated anti-mouse IgA (eBiosciences), biotin-conjugated anti-mouse IgG3 (BD Biosciences), biotin-conjugated anti-mouse IgG1 (BD Biosciences), PE-conjugated anti-mouse CD19 (eBiosciences) and APC-conjugated Streptavidin (eBiosciences) in FACS buffer (PBS, 0.5% BSA and 2mM EDTA). Splenic cell suspensions were stained after red-blood cell lysis using purified anti-mouse CD16/CD32 (BD Biosciences), Alexa Fluor 488-conjugated anti-human/mouse GL-7 (eBiosciences), PE-conjugated anti-mouse CD95 (BD Biosciences), PCP-Cy5.5-conjugated anti-mouse CD19 (eBiosciences), biotin-conjugated peanut agglutinin (PNA) and APC-conjugated Streptavidin (eBiosciences) in FACS buffer. Dead cell exclusion was carried out by staining with 7-AAD or DAPI. For intracellular detection of μ heavy-chains, cells were stained on the cell surface with purified anti-mouse CD16/CD32 (BD Biosciences), PCP-Cy5.5-conjugated anti-mouse CD19 (eBiosciences), APC-conjugated anti-mouse B220 (eBiosciences) and PE-conjugated anti-mouse CD138 (Biolegend) and subsequently washed in PBS and fixed in PBS, 2% PFA. After permeabilization in 0.5% Saponin in FACS buffer, cells were stained with Alexa Fluor 488-conjugated anti-mouse μ heavy-chain (ThermoFischer). Samples were acquired on a FACSCalibur or LSRFortessa X-20 flow cytometer (BD Biosciences) and analyzed with FlowJo software (Tree Star).

### Cell proliferation and cell cycle analyses {#sec4.4.6}

For analysis of cell proliferation, 10x10^6^ cells were stained with 2.5 μM carboxyfluorescein succinimidyl ester (CFSE, Biolegend) in 2 mL staining buffer (0.1% BSA in PBS at 37°C) for 10 min at room temperature. The reaction was stopped by adding cells to 40 mL ice-cold RPMI-1640 culture medium. Cells were washed twice and cultured for 3 days before FACS analysis. Cell cycle profiles were obtained by adding 10 μM of 5-bromo-2′-deoxyuridine (BrdU, Sigma-Aldrich) to 0.5-1x10^6^ CH12 cells 1 hr before harvesting. Cells were washed in PBS, fixed in ice-cold 70% ethanol and kept overnight at 4°C. For BrdU staining, cells were incubated in 2N HCl, 0.5% Triton X-100 for 30 min at room temperature followed by a 2 min incubation in 0.1 M sodium tetraborate buffer, pH 8.0. Cells were washed in PBS, 1% BSA and incubated with 2 μL FITC-conjugated anti-BrdU antibody (BioLegend) diluted in PBS, 1% BSA and 0.5% Tween-20 for 1 hr at room temperature. Cells were washed once and stained with 0.02 mg/mL propidium iodide (PI) in PBS, 0.1% Triton X-100, 0.2 mg/mL RNase A for 30 min at room temperature before FACS analysis.

### Lentiviral transduction of shRNA constructs and siRNA transfection {#sec4.4.7}

Stable expression of control shRNA (shCtrl, SHC002 Sigma-Aldrich) or DDX1-specific shRNA was obtained by lentiviral transduction of CH12 cells using the pLKO.1-puro system (SHC001 Sigma-Aldrich). Viral supernatants were produced in 293T cells (10 cm plates in DMEM supplemented with 10% heat-inactivated FBS) transfected with 9 μg psPAX2 packaging vector (Addgene), 3 μg pMD2.G envelope vector (Addgene) and 12 μg pLKO.1-puro shRNA vector using Lipofectamine 2000 according to manufacturer's instructions (ThermoFischer). Medium was replaced to complete RPMI-1640 24 hr after transfection to begin viral production. Viral supernatant was collected 48-72 hr after transfection and mixed with polybrene (8 μg/mL; Sigma-Aldrich). CH12 cells were resuspended in viral supernatants at a density of 0.2 × 10^6^ cells per mL and selected in puromycin (2 μg/mL; Sigma-Aldrich) 24 hr after infection for up to 7 days. Individual clones were isolated by serial dilution assays in the presence of puromycin and grown as independent shCtrl and shDDX1 CH12 cell lines. For transient depletion of DDX1, 30 pmol of short-interfering (siRNA) was electroporated into 3x10^6^ CH12 cells using Amaxa Cell Line Nucleofector Kit R (Lonza). A pool of 4 siRNAs was used to target mouse DDX1 (SMARTpool: siGENOME DDX1 siRNA, Dharmacon) as well as a control siRNA against Luciferase (Anti-Luc siRNA-1, Dharmacon).

### CRISPR/Cas9-mediated targeted deletion {#sec4.4.8}

Guide RNA sequences were designed using an online tool (<http://tools.genome-engineering.org>). A single guide RNA oligonucleotide targeting mouse *DDX1* exon 5 was cloned into pSpCas9(BB)-2A-Puro (PX459) (Addgene). Gene blocks containing *Aicda* guide RNA sequences were cloned using TOPO PCR cloning kit (ThermoFischer) and used in combination with hCas9_D10A mutant plasmid (Addgene). Guide RNA/Cas9 expression vectors were electroporated into CH12 cells using Amaxa Cell Line Nucleofector Kit R (Lonza) and cells were cloned using serial dilution assays 72 hr after transfection. Individual clones were screened for homozygous deletion using PCR and the genomic sequence of candidate alleles obtained by Sanger sequencing. Gene deletion was confirmed at the protein level by immunoblot.

### Expression of DDX1 dominant-negative mutant {#sec4.4.9}

Human DDX1 cDNA was amplified from HEK cells (see [Table S4](#mmc1){ref-type="supplementary-material"} for primer sequences) and cloned in frame with an N-terminal eGFP tag in the pcDNA3.1 vector (ThermoFischer). A mutant version of DDX1 where a conserved lysine residue in the Walker A motif I was mutated to alanine (K52A) was generated with QuikChange Site-Directed Mutagenesis kit (Agilent Technologies). CH12 cells were electroporated using Amaxa Cell Line Nucleofector Kit R (Lonza) and cultured at a density of 0.2 or 0.08 × 10^6^ cells per mL for analyses after 24 or 40 hr, respectively. GFP positive cells were FACS sorted using a MoFlo Astrios EQ (Beckman Coulter) before Immunoblot or DIP analyses.

### Protein extracts and western blot analysis {#sec4.4.10}

Whole-cell extracts were prepared in RIPA lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS, 10% glycerol) supplemented with a cocktail of protease and phosphatase inhibitors (Pierce). Cells were resuspended in 250 μL lysis buffer (5x10^6^ cells), incubated for 30 min on ice and centrifuged (17,000 g at 4°C for 10 min). For nuclear protein extracts, 10x10^6^ cells were resuspended in 500 μL cell lysis buffer (50 mM Tris-HCl, pH 8, 300 mM Sucrose, 4 mM MgAc, 12.5 mM KCl, 1 mM DTT, 10 mM β-mercaptoethanol, 0.3% NP-40 and 1mM PMSF) and incubated 5 min on ice followed by centrifugation (500 g for 10 min at 4°C). The nuclear pellet was resuspended in 250 μL buffer B (50 mM Tris-HCl pH 7.5, 25 mM KCl, 5 mM MgCl~2~ and 1 mM PMSF), overlaid in 250 μL buffer B containing 200 mM sucrose and centrifuged again to avoid cytoplasm carry over. High-salt extraction of nuclear proteins was carried out on ice for 30 min in 150 μL buffer C (20 mM HEPES pH 7.9, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2 mM DTT and 1 mM PMSF) followed by centrifugation (17,000 g at 4°C for 10 min). Protein concentration was measured using Bio-Rad Protein Assay. Typically, 10 μg of whole-cell and 20 μg of nuclear protein extracts were used for immunoblot with anti-DDX1 (NovusBiologicals or ProteinTech), anti-AID (Cell Signaling L7E7), anti-Tubulin (Sigma-Aldrich), anti-Actin (Sigma-Aldrich), anti-CTCF (Millipore) or anti-Histone H3 (Abcam) and HRP-conjugated secondary antibodies in TBST, 5% milk (Sigma-Aldrich). For immunoblot analysis of RNA pull-down or co-Immunoprecipitation assays the following antibodies were additionally used: anti-FLAG (ThermoScientific), anti-FLAG-HRP (Sigma) and anti- HSPC117/FAAP (RTCB) (Santa Cruz). Relative quantification of protein bands was done using ImageJ.

### Nuclear RNA fractionation {#sec4.4.11}

Nuclear RNA fractionation was performed as previously described ([@bib16]). Briefly, 2.5x10^6^ cells were resuspended in 500 μL of ice-cold RLB buffer (10 mM Tris-HCl, pH 7.5, 140 mM NaCl, 0.5% NP-40, 1.5 mM MgCl~2~) and lysed by adding an equal volume of RLB buffer with 24% (m/v) sucrose. Nuclei were isolated by centrifugation (900 g at 4°C for 10 min) and resuspended in 120 μL of NUN1 buffer (20 mM Tri-HCl, pH 7.9, 75mM NaCl, 0.5 mM EDTA, 50% Glycerol, 0.125 mM PMSF, 1mM DTT), followed by the addition of 1.2 mL NUN2 buffer (20 mM HEPES-NaOH pH 7.6, 7.5mM MgCl~2~, 0.2 mM EDTA, 300 mM NaCl, 1 M urea, 1% NP-40, 1 mM DTT). Nuclei were incubated on ice for 15 min and mixed by vortexing for 5 s every 5 min. Nucleoplasm and chromatin fractions were separated by centrifugation (14,000 g at 4°C for 10 min). The nucleoplasm fraction RNA was extracted with phenol-chloroform pH 4.3 and ethanol precipitated. The precipitate was resuspended in 200 μL of TURBO DNase buffer plus 4 U TURBO DNase (Ambion), incubated for 30 min at 37°C, then extracted with phenol-chloroform pH 4.3 and ethanol precipitated. Chromatin pellets were resuspended in 200 μL high salt buffer (10 mM Tris-HCl, pH 7.5, 500 mM NaCl, 10 mM MgCl~2~) and treated with 4U TURBO Dnase for 20 min at 37°C, followed by 200 μL Proteinase K/SDS mix (16 U Proteinase K (Roche), 2% SDS) for 20 min at 37°C. The chromatin-associated (chRNA) RNA was extracted with phenol-chloroform pH 4.3 and ethanol precipitated. The precipitate was twice resuspended in 200 μL of 1x TURBO DNase buffer plus 4 U TURBO Dnase, incubated for 30 min at 37°C, then extracted with phenol-chloroform pH 4.3 and ethanol precipitated. RNA was resuspended in 50 μL nuclease-free water (Ambion).

### Quantitative PCR and High-throughput Sequencing Library preparation {#sec4.4.12}

Total RNA, extracted using TRIzol (ThermoFischer), or nuclear RNA fractions (1 μg) were used for cDNA synthesis with random hexamers and Superscript III Reverse Transcriptase according to manufacturer's instructions (ThermoFischer). cDNA was diluted 10x in nuclease-free water (Ambion) before it was used for quantitative PCR analysis in a Rotor-Gene Q real-time PCR cycler (QIAGEN), using SYBR Green Master Mix (QIAGEN) and gene-specific primers ([Table S4](#mmc1){ref-type="supplementary-material"}). Minus Superscript III Reverse Transcriptase reactions were used as a control for contaminating DNA and relative gene expression levels were calculated using the ΔCt method. Before high-throughput sequencing library preparation, 2.5 μg chRNA was depleted for rRNA using the Ribo-Zero rRNA Removal kit according to manufacturer's instructions (Illumina). Libraries were prepared from 100 ng RNA using the NEBNext Ultra Directional RNA Library Prep kit and NEBnext Multiplex Oligos (Index Primers Set 2) for Illumina according to manufacturer's instructions (NEB). High-throughput sequencing was performed on a HiSeq 4000 sequencer (Illumina) with 75 bp paired-end reads.

### DNA immunoprecipitation (DIP) analysis to measure R-loop levels {#sec4.4.13}

DIP was performed as previously described ([@bib62]). Without prior cross-linking, 2.5-3x10^6^ cells were washed twice in PBS and lysed in 500 μL cell lysis buffer (5 mM PIPES pH 8.0, 85 mM KCl, 0.5% NP-40, 0.5 mM PMSF and complete protease inhibitor cocktail (Roche)) for 10 min on ice. Nuclei were isolated by centrifugation (900 g at 4°C for 5 min), resuspended in 400 μL ice-cold nuclear lysis buffer (50 mM Tris-HCl pH 8.0, 1% SDS, 10 mM EDTA, complete protease inhibitor cocktail) and incubated with 6 U of proteinase K (Roche) at 55°C for 3 hr. Genomic DNA was isolated, followed by sonication to 100-500 bp fragments in IP dilution buffer (16.7 mM Tris-HCl pH 8.0, 0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 167 mM NaCl, 0.5 mM PMSF, complete protease inhibitor cocktail) using a Bioruptor (Diagenode). DIP was carried out using the S9.6 antibody ([@bib4]) overnight at 4°C followed by 2 hr with Protein A Dynabeads (ThermoFischer). Immunoprecipitated (IP), no antibody control (-) and input DNA samples were used as templates for quantitative PCR analysis in a Rotor-Gene Q real-time PCR cycler (QIAGEN), using SYBR Green Master Mix (QIAGEN) and primers spanning the entire mouse *IgH* μ and α regions ([Table S4](#mmc1){ref-type="supplementary-material"}). DIP signals were validated by sensitivity to 10 U of Rnase H (Roche) treatment for 2 hr at 37°C prior to the immunoprecipitation step.

### Chromatin immunoprecipitation (ChIP) analysis {#sec4.4.14}

ChIP was performed using similar procedures to DIP with some modifications. Briefly, 2.5-3x10^6^ cells were cross-linked with 1% formaldehyde for 10 min at 37°C, quenched with 0.125 M Glycine and washed twice in PBS before resuspension in nuclear lysis buffer containing 0.5% SDS. Chromatin sonicated to 100-500 bp fragments was diluted in IP dilution buffer and pre-cleared with Protein G Dynabeads (ThermoFischer) for 1 hr at 4°C. Pre-cleared supernatants were immunoprecipitated with anti-AID antibody ([@bib7]) or rabbit IgG overnight at 4°C, followed by 2 hr with Protein G Dynabeads. Immunoprecipitated (IP), IgG control and input DNA samples were used as templates for quantitative PCR analysis in a Rotor-Gene Q real-time PCR cycler (QIAGEN), using SYBR Green Master Mix (QIAGEN) and primers spanning the entire mouse *IgH* μ and α regions ([Table S4](#mmc1){ref-type="supplementary-material"}).

### RNA pull-down assay {#sec4.4.15}

RNA folding and pull-down assays were performed as previously described ([@bib72]). Synthetic 5′-biotinylated Sμ4G and Sμ4Gmut RNA oligonucleotides (Integrated DNA technologies) were diluted to 5 μM in folding buffer (20 mM Tris-HCl pH 7.6, 1 mM EDTA and 100 mM KCl or 100 mM LiCl), heated at 95°C for 5 min and then allowed to cool at room temperature. To confirm the presence of G4 RNA, circular dichroism (CD) spectra were obtained in a Chirascan CD Spectrometer (Applied Photophysics Limited) at 25°C, with wavelength scan range of 220-320 nm and path length of 1 mm. Spectra were subtracted for buffer controls and smoothing was performed using Prism software. Alternatively, 10 pmoles of Sμ4G-KCl, Sμ4G-LiCl, Sμ4Gmut-LiCl or Sμ4Gmut-KCl were resolved in a 6% TBE agarose gel, transferred to a positively charged nylon membrane (Hybond N+) in 0.5x TBE at 30V for 1 hr. After UV-crosslinking, biotinylated RNA on the membrane was detected with HRP-conjugated Streptavidin (ThermoScientific) in TBST, 5% BSA. For RNA pull-down, whole cell extracts where prepared from CH12 cells cultured at a density of 0.06 × 10^6^ cells per mL in CIT stimulated conditions for 48 hr. RIPA lysis buffer without glycerol and with 2 mM EDTA was used. Extracts were pre-cleared at 4°C for 1 hr with Streptavidin MagneSphere Paramagnetic beads (Promega). Pre-cleared lysate (the equivalent to 1x10^6^ cells) was diluted with an equal volume of 2x Binding buffer (50 mM Tris-Acetate pH 7.8,10 mM NaCl, 3mM MgCl~2~, 70 mM glycine, 10% glycerol containing 100 mM KCl or 100 mM LiCl) and incubated with biotinylated oligonucleotides (200 pmol) for 1 hr at room temperature. Streptavidin MagneSphere Paramagnetic beads (Promega) were then added and incubated for an additional 1 hr. Beads were washed thrice with RIPA and once with PBS before bound proteins were recovered in 2x SDS loading buffer (5 min at 65°C plus boiling at 95°C) and analyzed by immunoblot. Bound RNAs were recovered by incubating beads in Trizol (ThermoFischer) and analyzed by dot blot using HRP-conjugated Streptavidin.

### Electromobility Shift Assay (EMSA) {#sec4.4.16}

Synthetic oligonucleotides (12.5 pmols, Integrated DNA Technologies; ([@bib10], [@bib14], [@bib72])) were 5′ end labeled by phosphorylation with \[γ-^32^P\]ATP and T4 polynucleotide kinase (PNK, NEB) for 1 h at 37 °C. Radiolabeled RNA was purified in a MicroSpin G-25 column (GE Healthcare) and precipitated in 0.3M sodium acetate, pH 5.2 and three volumes of ethanol. After centrifugation and a washing step with 70% ethanol the labeled oligos were resuspended in 200 μL of nuclease-free water (Ambion) and RNA was quantified by scintillation counting. Binding reactions were performed at 25°C for 10 min by mixing 1, 2 or 4 μg recombinant human DDX1 protein (amino acids 1-728 ([@bib28]); diluted to 0.25, 0.5 or 1 μg/μL in 10 mM HEPES-NaOH pH 7.9, 250 mM KCl, 5 mM MgCl~2~, 3 mM DTT) with 1 μL labeled oligo in a 20 μL final volume. Reactions were performed in binding buffer (10.4 mM HEPES-NaOH pH 7.9, 2 mM MgCl2, 1.6 mM MgAc, 1 mM DTT, 7.6% glycerol, 1.5 mM ATP and 2 mM GTP) and resolved on a native 4% polyacrylamide gel (19:1) at 25 mAmp for 3h in 1 × running buffer (75 mM Tris-HCL, 75 mM glycine pH 7.5-7.7) buffer at 4 °C. The gel was then dried on 3 MM Whatman filter paper and exposed with autoradiographic XAR film (Kodak).

### *In vitro* RNA:DNA hybrid assay {#sec4.4.17}

Tetramolecular G4 RNA forming oligonucleotides ([@bib10]) (Dharmacon) were annealed in 10 mM Tris-HCl pH 8, 50 mM KCl buffer at a concentration of 100 μM, after heating at 99°C for 20 min and slowly cooling to 4°C over several hours. 5′ end labeling of G4 RNA followed by MicroSpin G-25 column purification was performed as described before. G4 RNA was further purified by electrophoresis on a native 12% polyacrylamide gel, band excision and elution in 0.5 M NaOAc, 1 mM EDTA and 0.1% SDS buffer for 3 hr at 4°C. After ethanol precipitation, G4 RNA was resuspended in nuclease-free water and quantified by scintillation counting. *In vitro* formation of RNA:DNA hybrids was determined by mixing 1 μg recombinant human DDX1 protein (amino acids 1-728, ([@bib28]); diluted to 1 μg/μL in 10 mM HEPES-NaOH pH 7.9, 250 mM KCl, 5 mM MgCl~2~, 3 mM DTT) with approximately 2.5 fmol labeled G4 RNA and an equivalent amount of complementary DNA strands (Sigma-Aldrich) in a 20 μL final volume. The reaction was performed in binding buffer containing 5 mM MgCl2 and 5 mM ATP at 25°C for 10, 20 or 30 min. The presence of RNA:DNA hybrids was confirmed by treatment with 0.5 U RNaseH (Roche) for 20 min at 37°C in a final concentration of 10 mM MgCl~2~ and 50 mM NaCl. Nucleic acids were resolved on a native 12% polyacrylamide gel (19:1) at 100 V for 1 h 15 min in 1 × TBE buffer at 4 °C. The gel was exposed with a phosphor screen (Fujifilm) at −80 °C.

### Immunofluorescence assay {#sec4.4.18}

Approximately 2x10^6^ cells were fixed with PBS, 4% PFA and permeabilized with PBS, 0.25% Triton X-100. Before staining, cells were incubated in block buffer (PBS, 3% BSA) for 30 min at room temperature. Primary antibody anti-AID (Cell Signaling, clone 30F12) was added at 1:100 for 2 h at 4°C. Cells were washed 3x in wash buffer (PBS, 0.05% Tween20) by centrifugation (700 g at 4°C for 5 min). Secondary antibody Alexa Fluor 488-conjugated anti-rabbit IgG (ThermoFischer) was added at 1:500 for 1 hr at room temperature. Cells were washed 3x in wash buffer (PBS, 0.05% Tween20) and 2x in PBS by centrifugation (700 g at 4°C for 5 min). Cell slides were prepared by cytospin and mounted with Vectashield mounting media with DAPI (Vector Laboratories). Z stack images were collected with a FluoView1000 confocal microscope (Olympus) using a UPLSAPO 60.0X / 1.35 oil objective. Images were analyzed using ImageJ and prepared using OMERO software.

### Co-Immunoprecipitation {#sec4.4.19}

Cells were resuspended in 1x packed cell volume (PCV) of buffer A (10 mM HEPES, pH 7.9, 1.5 mM MgCl~2~, 10 mM KCl) and incubated 15 min on ice, followed by cell disruption using a 25G needle. After centrifugation (900 g at 4°C for 10 min) the nuclear pellet was resuspended in 1x PCV buffer C (20 mM HEPES, pH 7.9, 1.5 mM MgCl~2~, 420 mM NaCl, 25% glycerol), vortexed 10x and incubated 30 min at 4°C on a rotating wheel. Subsequently, nuclear lysates were diluted 3x in 50 mM HEPES pH 7.9, 0.1% Triton X-100 and 1 μL Benzonase (Sigma) was added per each 100 μL lysate. Benzonase digestion was carried out at 37°C for 30 min followed by centrifugation (17,000 g at 4°C for 10 min). Protein concentration was measured using Bio-Rad Protein Assay and 200 μg of nuclear lysate was used per immunoprecipitation in a final volume of 500 μL IP buffer (50 mM HEPES pH 7.9, 0.1% Triton X-100, 150 mM NaCl) with 1.5 μg anti-DDX1 (ProteinTech) or rabbit IgG (Sigma). Immunoprecipitation reactions were incubated at 4°C overnight on a rotating wheel, followed by 2 hr with M280 anti-rabbit IgG Dynabeads (ThermoFischer). Beads were washed 3x with IP buffer and protein complexes were eluted in 15 μL 0.2 M Glycine pH 2.6 (10 min at room temperature). Eluates were neutralized with 5 μL 1M Tris-HCl pH 8 and analyzed by immunoblot.

### Sμ mutations and microhomology analysis at Sμ-Sα junctions {#sec4.4.20}

Genomic DNA was isolated and recombined Sμ-Sα sequences were amplified by PCR (35 cycles of 98°C 10 s, 68°C 2 min 30 s) using high fidelity PrimeSTAR HS DNA Polymerase (Tanaka) (see [Table S4](#mmc1){ref-type="supplementary-material"} for primer sequences). PCR products spanning 1--2 kb were gel-extracted with QiaexII gel extraction kit (QIAGEN) and cloned using StrataClone Blunt PCR cloning kit (Agilent). DNA from individual clones was sequenced with T7 and T3 primers and NCBI blast was used for sequence alignment with germline switch sequences (obtained from Genome Reference Consortium Mouse Build 38). Sμ sequences were analyzed for mutation frequency as the number of individual mutations at each nucleotide out of the total number of nucleotides analyzed per experiment. The length of microhomology (MH) at Sμ--Sα junctions was measured as the number of consecutive nucleotides with perfect homology. Insertions were defined as nucleotides at the breakpoints with no homology to either of the S-regions. Only Sμ--Sα sequences with a unique pattern of Sμ mutation were considered for these analyses.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### ChRNA-seq data processing and bioinformatics analysis {#sec4.5.1}

Chromatin-associated RNA (chRNA) sequencing reads were aligned to the mouse genome (mm10), obtained from University of California at Santa Cruz (UCSC) using BWA ([@bib32]) with default parameters. Prior to alignment, adaptor sequences were trimmed using Cutadapt 1.8.3 ([@bib37]), discarding reads with less than 10 bases. An in-house Perl script was used to remove the reads left unpaired. Only uniquely aligned reads with no more than two mismatches were kept for further analysis. Data were scaled to library size (genomeCoverageBed) using Bedtools ([@bib53]). Bigwig track files were generated from the BWA output files using UCSC bedGraphToBigWig tool ([@bib29]). Gene annotation information was downloaded from the UCSC table browser for Refseq Genes. Cufflinks 2.2.0 ([@bib64]) was used for abundance estimation and quantification of transcripts. Differentially expressed genes between shCtrl and shDDX1 in unstimulated (UNS) or anti-CD40, IL-4 and TGF-β (CIT) stimulation conditions were identified using Cuffdiff 2.0.2. We included two biological replicates for each condition analyzed. A heatmap was generated with the R-package gplots using a subset of significantly altered genes (fold-change ≥ 2, False discovery rate (FDR) ≤ 0.05) identified by differential gene expression in either shCtrl/shDDX1 or UNS/CIT comparisons. Expression values for these genes were log transformed and quantile normalized before plotting the heatmap with rows denoting genes and columns denoting sample conditions.

### Statistical analysis {#sec4.5.2}

Statistical details of experiments are described in the figure legends. Results are expressed as mean values and standard deviation (SD) and n corresponds to the number of independent experiments. Statistical significance was analyzed using a two-tailed Student's t test and a paired test was used when samples were normalized. A Fisher's exact test was used for the analyses of microhomology length at Sμ-Sα junctions ([Figure S7](#mmc1){ref-type="supplementary-material"}C). ^∗^p ≤ 0.05 and ^∗∗^p ≤ 0.01 were considered significant.

Data Availability {#sec4.6}
-----------------

The accession number for the ChRNA-seq data reported in this paper is GEO: [GSE95635](ncbi-geo:GSE95635){#intref0025}. Raw image files have been deposited in the Mendeley Data repository (<https://data.mendeley.com/datasets/z747pf6sd9/draft?a=c2b73047-5f9c-4ad9-b65a-9894f4fedfb0>).
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